Establishment Labs Holdings logo

Establishment Labs HoldingsNASDAQ: ESTA

Profile

Sector:

Healthcare

Country:

Costa Rica

IPO:

19 July 2018

Next earnings report:

07 November 2024

Last dividends:

N/A

Next dividends:

N/A
$1.27 B
-37%vs. 3y high
75%vs. sector
-vs. 3y high
-vs. sector
-97%vs. 3y high
98%vs. sector
-49%vs. 3y high
72%vs. sector

Price

after hours | Fri, 01 Nov 2024 20:02:08 GMT
$45.42+$2.42(+5.63%)

Dividend

No data over the past 3 years
$44.12 M$40.45 M
$44.12 M-$17.18 M

Analysts recommendations

Institutional Ownership

ESTA Latest News

Establishment Labs Receives U.S. FDA Approval for Motiva Implants
businesswire.com26 September 2024 Sentiment: POSITIVE

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round breast implants in primary and revision breast augmentation. “Today's approval is transformative for breast aesthetics in.

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
zacks.com06 August 2024 Sentiment: NEUTRAL

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago.

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
zacks.com25 June 2024 Sentiment: POSITIVE

Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
Seeking Alpha28 February 2024 Sentiment: POSITIVE

Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript

Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research28 February 2024 Sentiment: POSITIVE

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.55 per share a year ago.

Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research21 February 2024 Sentiment: NEGATIVE

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Establishment Labs Stock Is Crashing Today
The Motley Fool08 November 2023 Sentiment: NEGATIVE

Establishment Labs missed consensus revenue and earnings estimates in Q3. The company also slashed its full-year guidance.

Establishment Labs Holdings Inc. (ESTA) Q3 2023 Earnings Call Transcript
Seeking Alpha07 November 2023 Sentiment: POSITIVE

Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Juan Jose Chacon Quiros - Founder and Chief Executive Officer Raj Denhoy - Chief Financial Officer Conference Call Participants Mike Sarcone - Jefferies Allen Gong - JPMorgan Anthony Petrone - Mizuho Group Josh Jennings - TD Cowen Neil Chatterji - B. Riley Joanne Wuensch - Citibank Sam Eiber - BTIG George Sellers - Stephens Operator Good afternoon.

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Lags Revenue Estimates
Zacks Investment Research07 November 2023 Sentiment: NEGATIVE

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.76 per share a year ago.

Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research31 October 2023 Sentiment: POSITIVE

Establishment Labs Holdings Inc. (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What type of business is Establishment Labs Holdings?

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

What sector is Establishment Labs Holdings in?

Establishment Labs Holdings is in the Healthcare sector

What industry is Establishment Labs Holdings in?

Establishment Labs Holdings is in the Medical Devices industry

What country is Establishment Labs Holdings from?

Establishment Labs Holdings is headquartered in Costa Rica

When did Establishment Labs Holdings go public?

Establishment Labs Holdings initial public offering (IPO) was on 19 July 2018

What is Establishment Labs Holdings website?

https://www.establishmentlabs.com

Is Establishment Labs Holdings in the S&P 500?

No, Establishment Labs Holdings is not included in the S&P 500 index

Is Establishment Labs Holdings in the NASDAQ 100?

No, Establishment Labs Holdings is not included in the NASDAQ 100 index

Is Establishment Labs Holdings in the Dow Jones?

No, Establishment Labs Holdings is not included in the Dow Jones index

When was Establishment Labs Holdings the previous earnings report?

No data

When does Establishment Labs Holdings earnings report?

The next expected earnings date for Establishment Labs Holdings is 07 November 2024